The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of disorders affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also expected
to release the results of research on the security of testosterone. The study involved approximately 800 older men with low testosterone and symptoms related to this condition, for example http://tinyurl.com/zwvtvex
physical and sexual dysfunction. Since the men's heart health was monitored, the research is expected to shed more light on the safety of testosterone treatment.
The recent contradictory findings on testosterone therapy prompted Patel and his team to conduct a substantial systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among men. An estimated 13 million men in the USA suffer from low testosterone, which happens when the body fails to make enough hormones because of a difficulty with the testicles or pituitary gland. This clarifies clear aging, somebody's sudden weight gain and loss of energy.
And many girls have a knee-jerk suspicion that any hormone treatment can raise their risk of breast cancer. However, clinical studies show that testosterone not only does not increase a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser thinks this will probably remain the status quo for a little while, given the prohibitive cost of conducting the long-term safety studies needed to gain FDA acceptance that is fuller.